Carregant...
Pembrolizumab-associated autoimmune haemolytic anaemia
Treatment paradigms have recently changed with the introduction of immunotherapy; autoimmune toxicities that can arise are frequently very different from the more familiar chemotherapy toxicities. We present a clinical case of autoimmune haemolytic anaemia (AIHA) secondary to pembrolizumab occurring...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827724/ https://ncbi.nlm.nih.gov/pubmed/31653618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-229064 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|